Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2023 Earnings

Operator: Hello and thank you for standing by. My name is Andrew and I will be your conference operator today.

Related Keywords

Wuxi , Jiangsu , China , Australia , Canada , United States , Australian , Friedrich Finckenstein , Michael Yee , Jim Ziegler , Fred Vogt , Jean Marc Bellemin , Sara Pellegrino , Igor Bilinsky , Peter Lawson , Barclays , Roofing Companies , Iovance Biotherapeutics Inc , Corporate Communications , Nasdaq , Call Transcript May , Results Conference , Senior Vice President , Investor Relations , Interim President , Chief Executive Officer , Chief Operating Officer , Executive Vice President , Chief Medical Officer , Chief Financial , Aviraj Puri , Regulatory Strategy , Translational Medicine , Biologics License Application , Nowi D , Marc Bellemin , Cancer Treatment , Bioresearch Monitoring ,